|
1
|
Cheung NK and Dyer MA: Neuroblastoma:
Developmental biology, cancer genomics and immunotherapy. Nat Rev
Cancer. 13:397–411. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maris JM: Recent advances in
neuroblastoma. N Engl J Med. 362:2202–2211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brodeur GM: Neuroblastoma: Biological
insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Molenaar JJ, Koster J, Zwijnenburg DA, van
Sluis P, Valentijn LJ, van der Ploeg I, Hamdi M, van Nes J,
Westerman BA, van Arkel J, et al: Sequencing of neuroblastoma
identifies chromothripsis and defects in neuritogenesis genes.
Nature. 483:589–593. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Johnson E, Dean SM and Sondel PM:
Antibody-based immunotherapy in high-risk neuroblastoma. Expert Rev
Mol Med. 9:1–21. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Navid F, Armstrong M and Barfield RC:
Immune therapies for neuroblastoma. Cancer Biol Ther. 8:874–882.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang RK and Sondel PM: Anti-GD2 strategy
in the treatment of neuroblastoma. Drugs Future. 35:6652010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Louis CU, Savoldo B, Dotti G, Pule M, Yvon
E, Myers GD, Rossig C, Russell HV, Diouf O, Liu E, et al: Antitumor
activity and long-term fate of chimeric antigen receptor-positive T
cells in patients with neuroblastoma. Blood. 118:6050–6056. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Karin M and Greten FR: NF-kappaB: Linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ho E: Zinc deficiency, DNA damage and
cancer risk. J Nutr Biochem. 15:572–578. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Prasad AS and Kucuk O: Zinc in cancer
prevention. Cancer Metastasis Rev. 21:291–295. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liuzzi JP and Cousins RJ: Mammalian zinc
transporters. Annu Rev Nutr. 24:151–172. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aydemir TB, Liuzzi JP, McClellan S and
Cousins RJ: Zinc transporter ZIP8 (SLC39A8) and zinc influence
IFN-gamma expression in activated human T cells. J Leukoc Biol.
86:337–348. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Besecker B, Bao S, Bohacova B, Papp A,
Sadee W and Knoell DL: The human zinc transporter SLC39A8 (Zip8) is
critical in zinc-mediated cytoprotection in lung epithelia. Am J
Physiol Lung Cell Mol Physiol. 294:L1127–L1136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang C, Cui X, Sun X, Yang J and Li M:
Zinc transporters are differentially expressed in human non-small
cell lung cancer. Oncotarget. 7:66935–66943. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jeong J and Eide DJ: The SLC39 family of
zinc transporters. Mol Aspects Med. 34:612–619. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Taylor KM, Morgan HE, Smart K, Zahari NM,
Pumford S, Ellis IO, Robertson JF and Nicholson RI: The emerging
role of the LIV-1 subfamily of zinc transporters in breast cancer.
Mol Med. 13:396–406. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cousins RJ: A role of zinc in the
regulation of gene expression. Proc Nutr Soc. 57:307–311. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dreosti IE: Zinc and the gene. Mutat Res.
475:161–167. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Franklin RB and Costello LC: Zinc as an
anti-tumor agent in prostate cancer and in other cancers. Arch
Biochem Biophys. 463:211–217. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leitzmann MF, Stampfer MJ, Wu K, Colditz
GA, Willett WC and Giovannucci EL: Zinc supplement use and risk of
prostate cancer. J Natl Cancer Inst. 95:1004–1007. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu T, Sempos CT, Freudenheim JL, Muti P
and Smit E: Serum iron, copper and zinc concentrations and risk of
cancer mortality in US adults. Ann Epidemiol. 14:195–201. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He L, Girijashanker K, Dalton TP, Reed J,
Li H, Soleimani M and Nebert D: ZIP8, member of the
solute-carrier-39 (SLC39) metal-transporter family:
Characterization of transporter properties. Mol Pharmacol.
70:171–180. 2006.PubMed/NCBI
|
|
28
|
Franklin RB, Milon B, Feng P and Costello
LC: Zinc and zinc transporters in normal prostate and the
pathogenesis of prostate cancer. Front Biosci. 10:2230–2239. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kolenko V, Teper E, Kutikov A and Uzzo R:
Zinc and zinc transporters in prostate carcinogenesis. Nat Rev
Urol. 10:219–226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang LY, Wang XL, Sun DX, Liu XX, Hu XY
and Kong F: Regulation of zinc transporters by dietary flaxseed
lignan in human breast cancer xenografts. Mol Biol Rep. 35:595–600.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo JL, Kamata H and Karin M:
IKK/NF-kappaB signaling: Balancing life and death-a new approach to
cancer therapy. J Clin Invest. 115:2625–2632. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gatsinzi T and Iverfeldt K: Sensitization
to TRAIL-induced apoptosis in human neuroblastoma SK-N-AS cells by
NF-κB inhibitors is dependent on reactive oxygen species (ROS). J
Neurooncol. 104:459–472. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ammann JU, Haag C, Kasperczyk H, Debatin
KM and Fulda S: Sensitization of neuroblastoma cells for
TRAIL-induced apoptosis by NF-kappaB inhibition. Int J Cancer.
124:1301–1311. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
